23ANDME HOLDING CO -CLASS A (ME) Stock News
NASDAQ:ME - Nasdaq - US90138Q3065 - Common Stock - Currency: USD
ME Latest News, Press Relases and Analysis
Trump's Metal Tariffs Set Stage For US Steel ETF Gains
Tariffs on metal imports create opportunities in ETFs focused on U.S. steelmakers. Top picks are VanEck Steel, SPDR S&P Metals & Mining, and Global X U.S. Infrastructure Development ETF.
23andMe Launches New Genetic Report on Osteoporosis
Provides 23andMe+ Premium members with insight into their likelihood of developing osteoporosis based on thousands of genetic variants...
23andMe Launches New Genetic Report on Osteoporosis
Provides 23andMe+ Premium members with insight into their likelihood of developing osteoporosis based on thousands of genetic variants
23andMe Special Committee Announces Exploration of Strategic Alternatives
SUNNYVALE, Calif., Jan. 28, 2025 (GLOBE NEWSWIRE) -- The Special Committee of the Board of Directors of 23andMe Holding Co. (Nasdaq: ME) (“23andMe” or...
23andMe Special Committee Announces Exploration of Strategic Alternatives
23andMe Reports Third Quarter Fiscal Year 2025 Financial Results
Company Notes Continued Concerns Regarding Liquidity and Consideration of Potential Ways to Address Operational and Financial Challenges SUNNYVALE,...
23andMe Reports Third Quarter Fiscal Year 2025 Financial Results
23andMe Launches Discover23 to Help Accelerate Large-Scale Genetics Research For Biopharma Collaborators, Powered By Lifebit’s Trusted Technology
23andMe is helping collaborators better understand disease biology, identify novel targets, boost clinical trial success, and engage people in their care...
23andMe Launches Discover23 to Help Accelerate Large-Scale Genetics Research For Biopharma Collaborators, Powered By Lifebit’s Trusted Technology
23andMe is helping collaborators better understand disease biology, identify novel targets, boost clinical trial success, and engage people in their care
Want $500 of Reliable Dividend Income in 2025? Invest $5,040 in These 3 Ultra-High-Yield Stocks.
The Shake-Up at Intel
And cybersecurity consultant Dave Hatter helps us see what's really going on with all of our information.
23andMe and Mirador Therapeutics Enter Into Strategic Research Collaboration to Advance Mirador’s Precision Medicines for Immunology & Inflammation
SUNNYVALE, Calif. and SAN DIEGO, Nov. 20, 2024 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (Nasdaq: ME), a leading human genetics and preventive health...
23andMe Reports Second Quarter Fiscal Year 2025 Financial Results
SUNNYVALE, Calif., Nov. 12, 2024 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (Nasdaq: ME), a leading human genetics and preventive health company, reported...
23andMe Reports Second Quarter Fiscal Year 2025 Financial Results
23andMe Announces Business Restructuring to Streamline Operations, Reduce Costs and Position Company for the Future
Reduces workforce by roughly 40%; expects annualized cost savings of more than $35 million Discontinues development of therapeutics division and commences...
CORRECTION - 23andMe to Report Q2 FY2025 Financial Results
CORRECTION - 23andMe to Report Q2 FY2025 Financial Results
SUNNYVALE, Calif., Nov. 07, 2024 (GLOBE NEWSWIRE) -- An earlier release under the same headline should have noted 23andMe Holding Co. (Nasdaq: ME)...
23andMe to Report Q2 FY2025 Financial Results
SUNNYVALE, Calif., Nov. 07, 2024 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (Nasdaq: ME) (23andMe), a leading human genetics and biopharmaceutical company,...
23andMe to Report Q2 FY2025 Financial Results
23andMe Regains Compliance With Nasdaq Listing Requirements
SUNNYVALE, Calif., Oct. 30, 2024 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (Nasdaq: ME) (the “Company” or “23andMe”), a leading human genetics and...
23andMe Regains Compliance With Nasdaq Listing Requirements
23andMe Appoints Three New Independent Directors to Board
SUNNYVALE, Calif., Oct. 29, 2024 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (Nasdaq: ME) (the “Company” or “23andMe”), a leading human genetics and...
23andMe Appoints Three New Independent Directors to Board
Ancestry Says a 23AndMe Takeover Would Raise Antitrust Issues
Ancestry.com Inc. said a hypothetical takeover of its flailing rival in the consumer genetic testing industry, 23andMe Holding Co., likely wouldn’t be possible for antitrust reasons.
Mentions: ACOM
23andMe Introduces New Feature Helping African Americans Trace Their Roots to Post Slavery Communities in the South
The new African American Genetic Groups feature traces customers' ancestral connections from before the early-to-mid-20th century migrations to more than...
23andMe Introduces New Feature Helping African Americans Trace Their Roots to Post Slavery Communities in the South
The new African American Genetic Groups feature traces customers' ancestral connections from before the early-to-mid-20th century migrations to more than 200 communities in Southern states
23andMe Announces Completion of 1-for-20 Reverse Stock Split
SUNNYVALE, Calif., Oct. 16, 2024 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (Nasdaq: ME) (the “Company” or “23andMe”), announced today the completion of the...
23andMe Announces Completion of 1-for-20 Reverse Stock Split
23andMe Announces 1-for-20 Reverse Stock Split
SUNNYVALE, Calif., Oct. 11, 2024 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (Nasdaq: ME) (the “Company” or “23andMe”), announced today that the 1-for-20...
23andMe Announces 1-for-20 Reverse Stock Split
23andMe Announces Mathew Knowles as New Brand Ambassador
Collaboration to help increase awareness of the power of genetic testing when it comes to learning about personal health risks...
23andMe Announces Mathew Knowles as New Brand Ambassador
Collaboration to help increase awareness of the power of genetic testing when it comes to learning about personal health risks